期刊文献+

武汉江岸方舱医院472例新型冠状病毒肺炎临床特征分析 被引量:8

Clinical characteristics of 472 cases of novel coronavirus pneumonia in Wuhan Jiangan Makeshift(Fangcang)Hospital
下载PDF
导出
摘要 目的分析武汉江岸方舱医院新型冠状病毒肺炎(COVID-19)病例临床特征、转归,为本病的防治提供参考。方法回顾性分析2020年2月12日至2020年3月8日,武汉江岸方舱医院收治的472例COVID-19患者的临床资料,对比出院及转院患者的年龄、首发临床症状、胸部CT表现、合并症等方面是否存在差异。结果472例患者中,男(215例)女(257例)的比例是1∶1.2。首发临床症状以发热(75.4%)、干咳(50.0%)、乏力(20.1%)为主。87例(18.4%)患者合并慢性基础疾病。37例(7.8%)核酸阳性的患者没有任何临床症状,其中2例转院治疗。31例(6.5%)核酸阳性的患者胸部CT没有任何异常,均出院。57例(12.1%)患者病情加重,转院治疗,无死亡病例。出院组和转院组比较,在发热、干咳、胸闷憋气、周身酸痛、腹泻、寒战方面差异有统计学意义(P<0.05)。在发热为首发的临床症状病例中,两组在低热、高热、超高热方面差异有统计学意义(P<0.05)。出院患者和转院患者比较,在胸部CT表现病灶呈双肺弥漫性分布、病灶累及单个肺叶、多发病灶、单发病灶及没有任何异常方面差异有统计学意义(P<0.05)。46例患者行新型冠状病毒特异性抗体(IgG、IGM)检测,其中IgM、IgG均阳性8例,IgM阴性、IgG阳性38例,两个抗体均阴性0例。结论年龄大、基础疾病多、胸部CT表现为弥漫性病变,首发临床症状伴有发热(尤其是高热)、干咳、胸闷憋气、周身酸痛、腹泻、寒战的此类患者是COVID-19的高危人群,且易进展为(危)重患者。 Objective To analyze the clinical characteristics and outcome of coronavirus disease 2019(COVID-19)in Wuhan Jiangan Makeshift(Fangcang)Hospital for reference in prevention and treatment of this disease.Methods Retrospective analysis was conducted on the clinical data of 472 COVID-19 patients admitted to Wuhan JiangAn Makeshift(Fangcang)Hospital from February 12 to March 8,2020 to see whether there were differences among COVID-19 patients,discharged and transferred patients in terms of the age,first clinical symptoms,chest CT findings and complications.Results Of 472 patients,the ratio of males(215)to females(257)was 1∶1.2.The first clinical symptoms were mainly fever(75.4%),dry cough(50.0%)and fatigue(20.1%).There were 87 patients(18.4%)with chronic basic diseases.A total of 37(7.8%)patients with positive nucleic acid showed no clinical symptoms,and two of them were transferred for further treatment.Totally 31 patients(6.5%)with positive nucleic acid had no abnormal chest CT findings and were discharged from the hospital.And 57 patients(12.1%)became sicker and were transferred for further treatment.No deaths were reported.There were statistically significant differences between the discharged and the transferred patients in fever,dry cough,chest tightness,soreness,diarrhea and chills(P<0.05).Among the patients having clinical symptoms with fever as the first symptom,there were statistically significant differences in terms of low fever,high fever and ultra-high fever(P<0.05).There were statistically significant differences between discharged patients and transferred patients in terms of the diffuse distribution of chest CT lesions in both lungs,the involvement of lesions in a single lobe,multiple lesions,single lesion and no abnormalities(P<0.05).Novel coronavirus specific antibodies(IgG,IGM)were tested in 46 patients,of which eight cases were tested positive for IGM and IgG,38 cases were tested negative for IGM and positive for IgG,and 0 was tested negative for both antibodies.Conclusion COVID-19 high-risk pop
作者 白敏 刘献强 吴伟强 孙凯 黄旭 靳怀宗 Bai Min;Liu Xianqiang;Wu Weiqiang;Sun Kai;Huang Xu;Jin Huaizong(Department of Respiratory Medicine,Tianjin Hongqiao Hospital,Tianjin 300131,China;Department of Cardiology,Tianjin Hongqiao Hospital,Tianjin 300131,China;Department of Emergency,Tianjin Hongqiao Hospital,Tianjin 300131,China;Department of Neurosurgery,Tianjin Hongqiao Hospital,Tianjin 300131,China;Department of Critical Care Medicine,Tianjin Hongqiao Hospital,Tianjin 300131,China;Wuhan Jiangan Makeshift(Fangcang)Hospital,Whhan 430000,China;Department of Orthopedics,Tianjin Beichen Hospital of Traditional Chinese Medicine,Tianjin 300400,China)
出处 《临床荟萃》 CAS 2020年第4期297-301,共5页 Clinical Focus
关键词 新型冠状病毒肺炎 方舱医院 临床特征 COVID-19 Makeshift(Fangcang)hospital Clinical characteristics
  • 相关文献

参考文献2

二级参考文献15

  • 1Kalden J. What is inflammation? Eur Heart J, 1987,8(suppl J): 1-5. 被引量:1
  • 2Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature,2007,449(7164):819-826. 被引量:1
  • 3Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol,2008,180(9):5771-5777. 被引量:1
  • 4Chen GY, Nufiez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol,2010,10(12):826-837. 被引量:1
  • 5Speyer CL, Ward PA. Role of endothelial chemokines and their receptors during inflammation. J Invest Surg,2011,24(1): 18-27. 被引量:1
  • 6Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci,2008,9(1):46-56. 被引量:1
  • 7Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest,2000,117(4): 1162-1172. 被引量:1
  • 8Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-3,. Mediators Inflamm,2001,10(2):51-59. 被引量:1
  • 9Asadullah K, Sterry W, Volk H. Interleukin-10 therapy--review of a new approach. Pharmacol Rev,2003,55(2):241-269. 被引量:1
  • 10Finlay BB, McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Ce11,2006,124(4):767-782. 被引量:1

共引文献123

同被引文献83

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部